187 related articles for article (PubMed ID: 35632764)
1. Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein.
Petersen JD; Lu J; Fitzgerald W; Zhou F; Blank PS; Matthies D; Zimmerberg J
Viruses; 2022 May; 14(5):. PubMed ID: 35632764
[TBL] [Abstract][Full Text] [Related]
2. The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles.
Petersen JD; Lu J; Fitzgerald W; Zhou F; Blank PS; Matthies D; Zimmerberg J
bioRxiv; 2022 Apr; ():. PubMed ID: 35441171
[TBL] [Abstract][Full Text] [Related]
3. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
[TBL] [Abstract][Full Text] [Related]
4. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
5. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.
Chen HY; Huang C; Tian L; Huang X; Zhang C; Llewellyn GN; Rogers GL; Andresen K; O'Gorman MRG; Chen YW; Cannon PM
J Virol; 2021 Oct; 95(22):e0096621. PubMed ID: 34495700
[TBL] [Abstract][Full Text] [Related]
7. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
[TBL] [Abstract][Full Text] [Related]
8. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
Peters MH; Bastidas O; Kokron DS; Henze CE
Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
[TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
Viruses; 2021 May; 13(6):. PubMed ID: 34064066
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
[TBL] [Abstract][Full Text] [Related]
11. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant.
Garcia C; Compagnon B; Ribes A; Voisin S; Vardon-Bounes F; Payrastre B
Front Immunol; 2023; 14():1231576. PubMed ID: 37828997
[TBL] [Abstract][Full Text] [Related]
13. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity.
Meng B; Datir R; Choi J; ; Bradley JR; Smith KGC; Lee JH; Gupta RK
Cell Rep; 2022 Aug; 40(7):111220. PubMed ID: 35963244
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes.
Chatterjee D; Tauzin A; Laumaea A; Gong SY; Bo Y; Guilbault A; Goyette G; Bourassa C; Gendron-Lepage G; Medjahed H; Richard J; Moreira S; Côté M; Finzi A
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062348
[TBL] [Abstract][Full Text] [Related]
16. A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern.
Zhang Z; Li J; Gu J; Amini R; Stacey HD; Ang JC; White D; Filipe CDM; Mossman K; Miller MS; Salena BJ; Yamamura D; Sen P; Soleymani L; Brennan JD; Li Y
Chemistry; 2022 Mar; 28(15):e202200078. PubMed ID: 35084794
[TBL] [Abstract][Full Text] [Related]
17. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
18. The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.
Wu J; Nie J; Zhang L; Song H; An Y; Liang Z; Yang J; Ding R; Liu S; Li Q; Li T; Cui Z; Zhang M; He P; Wang Y; Qu X; Hu Z; Wang Q; Huang W
Signal Transduct Target Ther; 2022 Jan; 7(1):18. PubMed ID: 35046385
[TBL] [Abstract][Full Text] [Related]
19. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
[TBL] [Abstract][Full Text] [Related]
20. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
